<?xml version="1.0" encoding="UTF-8"?>
<ref id="R14">
 <label>14</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Noordman</surname>
    <given-names>BJ</given-names>
   </name>, 
   <name name-style="western">
    <surname>Spaander</surname>
    <given-names>MCW</given-names>
   </name>, 
   <name name-style="western">
    <surname>Valkema</surname>
    <given-names>R</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study</article-title>. 
  <source>Lancet Oncol</source>
  <year>2018</year>;
  <volume>19</volume>:
  <fpage>965</fpage>â€“
  <lpage>74</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S1470-2045(18)30201-8</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/29861116?>
  <pub-id pub-id-type="pmid">29861116</pub-id>
 </mixed-citation>
</ref>
